Research Article

Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis

Figure 1

MAT reduces clinical signs of EAE. (a) Structure of MAT. (b) Effect-versus-time curves of MAT effects on EAE. Clinical EAE was scored daily after immunization according to a 0–5 scale. (c) The mean maximum clinical scores are expressed as mean ± SD ( each group). , compared to naive group; , compared to vehicle-treated group.
736085.fig.001a
(a)
736085.fig.001b
(b)
736085.fig.001c
(c)